News for Healthier Living

Study Aims to Establish Key Biomarkers in Rett Syndrome

Like many neurodevelopmental disorders, Rett syndrome has long had a lack of disease-specific treatments. But that landscape is poised to change. The Food and Drug Administration approved the first treatment for Rett, trofinetide, in 2023, and other novel therapies--including a potential gene therapy--are in the pipeline.

May 15, 2025


May 15 2025

May 14 2025

May 13 2025

May 12 2025

May 11 2025

May 10 2025

May 9 2025

May 8 2025

May 7 2025

May 6 2025

May 5 2025

May 2 2025